CTF1 and metabolic dysfunction-associated steatotic liver disease: Since previous studies indicated that both obesity and diabetes are confounding factors that affect the levels of CT-1, the relationship between CT-1 and CAP was therefore investigated after further adjustment for the confounding factors as shown in Model 2 of Table 2, having NAFLD (β = −374.76, 95% CI = −670.88~−78.65, p = 0.013) was independently associated with CT-1 after adjustment for sex, obesity, and diabetes (Model 2).